Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Low-dose B-vitamins Supplementation on Plasma Homocysteine and Framingham Risk Score: Double Blind Randomized Controlled Trial in Healthy Chinese Elderly

NCT00755664 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT00755664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00755664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Low-dose B-vitamins Supplementation on Plasma Homocysteine and Framingham Risk Score: Double Blind Randomized Controlled Trial in Healthy Chinese Elderly
Lead sponsor
Peking University
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2007
Completion date
September 30, 2012
Enrollment
390 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperhomocysteinemia